CompoAtlas

Vitamine D

Natural health product licensed in Canada

Other names
Vitamine D3
Licence holder
Fabmark Inc.
NPN or DIN-HM
80083036
Status
Active licence
Licence date
12 February 2018
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vitamine D

Source : Cholécalciférol

1,000 Unités internationalesNot calculated
Vitamine D

Source : Cholécalciférol

25 microgrammesNot calculated

Non-medicinal ingredients

Gélatine, farine de riz, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
Adultes, adolescents et enfantsminimum: 6 years1 Capsule1 Tous les jours

Uses authorised in Canada

Aide au développement et au maintien des os et des dents. Aide à l'absorption et à l'utilisation du calcium et du phosphore. La consommation de calcium, lorsqu'elle s'accompagne d'un apport suffisant en vitamine D, d'une alimentation saine, et de la pratique régulière d'une activité physique, peut réduire le risque d'ostéoporose. Aide à la formation des os et des dents solides. Aide au maintien des fonctions immunitaires. Aide au processus de division normale des cellules.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80083036

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line